BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) entered into a definitive purchase agreement with InterWest Partners X, LP, an affiliate of InterWest ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE